Top 10 Most Recent News Articles

CNL Strategic Capital Unveils Their New Follow-On Offering - Article Image
Category: News Total Views: 0
By : Hannah Lewis Updated: 11-01-2024
CNL Strategic Capital Launches Significant Follow-On OfferingCNL Strategic Capital, a non-traded public company focused on generating income and facilitating long-term appreciation for its investors, has initiated its second follow-on offering, allowing for the issuance of up to $1.1 billion in shares. This strategic move underscores the company's robust commitment to enhancing its investment portfolio.Investment Strategy OverviewThis offering will adhere to CNL Strat... Continue Reading
ALX Oncology's Promising Advances at Upcoming Symposium - Article Image
Category: News Total Views: 0
By : Dylan Bailey Updated: 11-01-2024
Exciting Developments from ALX OncologyALX Oncology Holdings Inc., a pioneering clinical-stage biotechnology company, has some promising news to share. Focused on revolutionizing cancer treatment through immune system enhancement, the company has announced significant findings from its Phase 1b/2 trial. This study evaluates evorpacept, ALX’s lead therapeutic candidate, in combination with zanidatamab.Details of the Clinical TrialThe trial targets patients with HER2-po... Continue Reading
Lite Access Technologies Adjusts Debenture Dates and Plans Growth - Article Image
Category: News Total Views: 0
By : Kelly Martin Updated: 11-01-2024
Lite Access Technologies Updates on Convertible DebenturesLite Access Technologies Inc. (NASDAQ: LTE, TSXV: LTCCF) has taken significant steps to bolster its future growth potential. The company has announced that it will extend the maturity date of its previously issued convertible debentures from November 22, 2024, to November 22, 2026. This strategic move reflects the confidence of all holders involved regarding their commitment to the company's future.Interest Rates and C... Continue Reading
LivaNova Secures Continued Classification for VNS Therapy - Article Image
Category: News Total Views: 0
By : Olivia Taylor Updated: 11-01-2024
LivaNova Secures Important Classification for VNS Therapy LivaNova PLC (NASDAQ: LIVN), a prominent player in the medical device sector, is pleased to announce that the U.S. Centers for Medicare and Medicaid Services (CMS) will maintain its reimbursement classification for VNS Therapy, specifically designed for drug-resistant epilepsy (DRE), at the current payment level for the year ahead. Despite expectations for a potential upgrade in reimbursement classification, the company has re... Continue Reading
New Leadership at Latino Corporate Directors Association Announced - Article Image
Category: News Total Views: 0
By : Hannah Lewis Updated: 11-01-2024
New Leadership at Latino Corporate Directors Association Announced The Latino Corporate Directors Association (LCDA) and its affiliated foundation, the Latino Corporate Directors Education Foundation (LCDEF), are thrilled to introduce an accomplished new Board of Directors for the upcoming 2025-2027 term. This significant move aims to strengthen their mission of promoting Latino representation in corporate governance. Commitment to Latino Representation With a firm co... Continue Reading
Digital Brands Group Faces Nasdaq Delisting Challenges - Article Image
Category: News Total Views: 1
By : Henry Turner Updated: 11-01-2024
The Current Situation of Digital Brands GroupDigital Brands Group, Inc. (NASDAQ:DBGI), a noted player in the retail apparel sector, is currently dealing with a potential delisting from the Nasdaq Stock Market due to a critical misstep regarding its share issuance.The Rule Violation ExplainedThe problem arose when Digital Brands Group's transfer agent mistakenly issued 1,311,345 shares of common stock to a note holder as a result of converting a promissory note. This a... Continue Reading
Eli Lilly Showcases Game-Changing Cancer Research at Annual Symposium - Article Image
Category: News Total Views: 1
By : Thomas Cooper Updated: 11-01-2024
Eli Lilly's Groundbreaking Research on Breast Cancer Eli Lilly and Company (NYSE: LLY) is set to present compelling data from their Phase 3 EMBER-3 study, focusing on imlunestrant, an innovative oral selective estrogen receptor degrader (SERD). This presentation will occur at the prestigious San Antonio Breast Cancer Symposium, showcasing the latest advancements in breast cancer treatment. Understanding the EMBER-3 Study The EMBER-3 trial is pivotal in examining the e... Continue Reading
Iterum Therapeutics Postpones Major Milestone Payment Strategy - Article Image
Category: News Total Views: 1
By : Owen Jenkins Updated: 11-01-2024
Iterum Therapeutics' Strategic Payment DeferralIterum Therapeutics plc (NASDAQ: ITRM), a growing pharmaceutical company, has recently made a significant decision to defer a $20 million milestone payment to Pfizer Inc. (NYSE: PFE). This development comes shortly after the U.S. Food and Drug Administration (FDA) granted approval for Iterum's ORLYNVAH™ (sulopenem etzadroxil and probenecid), designed specifically for treating uncomplicated urinary tract infections in adult women.... Continue Reading
Virtue Labs Celebrates Innovation with TIME Best Inventions Honor - Article Image
Category: News Total Views: 1
By : Lucas Young Updated: 11-01-2024
Virtue Labs Honored for Innovation in Hair Care Virtue Labs Receives TIME Recognition for Damage Reverse Serum Virtue Labs, a pioneering biotech hair care company, has proudly announced that its Damage Reverse Serum has been selected as one of TIME's Best Inventions of 2024. This accolade identifies the most groundbreaking innovations contributing to a better world. The Essence of Innovation Each year, TIME compiles a distinct list showcasing 200 ... Continue Reading
SiriusPoint Ltd Enhances Board with Strategic Appointment - Article Image
Category: News Total Views: 1
By : Lucas Young Updated: 11-01-2024
Strategic Board Appointment of Meng Tee Saw SiriusPoint Ltd, a leader in fire, marine, and casualty insurance, recently announced the appointment of Meng Tee Saw to its board of directors. This significant move comes as part of the company’s ongoing commitment to enhance its governance and oversight. Mr. Saw's term will commence shortly, bringing a new dynamic to the existing board. Background of Meng Tee Saw With a deep-rooted history in the accounting sector, Mr. Sa... Continue Reading

Recent Articles